|
|
|
|
| LEADER |
02824nam a22003735i 4500 |
| 001 |
978-3-540-92165-3 |
| 005 |
20191025052403.0 |
| 007 |
cr nn 008mamaa |
| 008 |
100301s2009 gw | s |||| 0|eng d |
| 020 |
|
|
|a 9783540921653
|
| 024 |
7 |
|
|a 10.1007/978-3-540-92165-3
|2 doi
|
| 040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
| 245 |
1 |
0 |
|a Vaccines for Pandemic Influenza
|c edited by Richard W Compans, Walter A. Orenstein.
|
| 250 |
|
|
|a 1st ed. 2009.
|
| 260 |
# |
# |
|a Berlin, Heidelberg :
|b Springer Berlin Heidelberg :
|b Imprint: Springer,
|c 2009.
|
| 300 |
|
|
|a XVIII, 512 p. 51 illus., 30 illus. in color.
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Current Topics in Microbiology and Immunology,
|v 333
|
| 505 |
0 |
|
|a Pandemic Influenza Overview -- Pandemic Influenza as a Current Threat -- Antigenic Cross-Reactivity Among H5N1 Viruses -- Current Approaches for Human and Avian Vaccine Production -- Seasonal Influenza Vaccines -- Generation and Characterization of Candidate Vaccine Viruses for Prepandemic Influenza Vaccines -- Live Attenuated Vaccines for Pandemic Influenza -- Influenza Vaccines for Avian Species -- Development and Application of Avian Influenza Vaccines in China -- Novel Vaccine Approaches -- Designing Vaccines for Pandemic Influenza -- Attenuated Influenza Virus Vaccines with Modified NS1 Proteins -- DNA Vaccines Against Influenza Viruses -- Recombinant Proteins Produced in Insect Cells -- Influenza Neuraminidase as a Vaccine Antigen -- Recombinant Vectors as Influenza Vaccines -- Influenza Virus-Like Particles as Pandemic Vaccines -- Pandemic Influenza Vaccines -- Adjuvants for Pandemic Influenza Vaccines -- Novel Approaches for Vaccine Delivery -- Transcutaneous Immunization with Influenza Vaccines -- Microneedle-Based Vaccines -- Vaccine Evaluation, Production and Distribution -- Animal Models for Evaluation of Influenza Vaccines -- Immunosenescence and Influenza Vaccine Efficacy -- Vaccines for Pandemic Influenza: Summary of Recent Clinical Trials -- Considerations for Licensure of Influenza Vaccines with Pandemic and Prepandemic Indications -- Strategies for Broad Global Access to Pandemic Influenza Vaccines -- Prioritization of Pandemic Influenza Vaccine: Rationale and Strategy for Decision Making.
|
| 650 |
|
0 |
|a Virology.
|
| 650 |
|
0 |
|a Pharmacology.
|
| 650 |
|
0 |
|a Public health.
|
| 650 |
|
0 |
|a Immunology.
|
| 650 |
1 |
4 |
|a Virology.
|
| 650 |
2 |
4 |
|a Pharmacology/Toxicology.
|
| 650 |
2 |
4 |
|a Public Health.
|
| 650 |
2 |
4 |
|a Immunology.
|
| 700 |
1 |
|
|a Compans, Richard W.
|e editor.
|
| 700 |
1 |
|
|a Orenstein, Walter A.
|e editor.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|
| 856 |
4 |
0 |
|u https://doi.org/10.1007/978-3-540-92165-3
|